The largest database of trusted experimental protocols

The LN229 is a laboratory equipment product. It is a cell line derived from human glioblastoma cells. The core function of the LN229 is to serve as a research tool for studying glioblastoma, a type of brain cancer.

Automatically generated - may contain errors

4 protocols using ln229

1

Cell Culture Protocols for EGFR Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
P3X63Ag8U.1 (P3U1), Chinese hamster ovary (CHO)-K1, LN229, and NMuMG (a mouse mammary gland epithelial cell) were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). Lewis lung carcinoma was obtained from the Japanese Collection of Research Bioresources (JCRB; Osaka, Japan).
The pCAG-zeo_ssnPA-mEGFR and pCAG-zeo_MAP-mEGFR plasmids were transfected into LN229 and CHO-K1 cells, respectively. The stable transfectants were generated as described previously [40 (link),41 (link)].
CHO-K1, mEGFR-overexpressed CHO-K1 (CHO/mEGFR), Lewis lung carcinoma, and P3U1 were cultured in an RPMI-1640 medium (Nacalai Tesque Inc., Kyoto, Japan), with 10% fetal bovine serum (FBS; Thermo Fisher Scientific Inc., Waltham, MA, USA). A cocktail of 100 units/mL of penicillin, 100 μg/mL of streptomycin, and 0.25 μg/mL of amphotericin B (Nacalai Tesque Inc.) was added to the medium. LN229, mEGFR-overexpressed LN229 (LN229/mEGFR), and NMuMG were cultured in DMEM (Nacalai Tesque Inc.), supplemented as indicated above. For NMuMG cells, 10 μg/mL of insulin (Sigma-Aldrich Corp., St. Louis, MO, USA) was further added. All cells were cultured using a humidified incubator at 37 °C, in an atmosphere of 5% CO2 and 95% air.
+ Open protocol
+ Expand
2

Cell Lines from Multiple Oncology Domains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human oral squamous cell carcinoma cell lines HSC‐3 and OSC‐19 were purchased from Health Science Research Resources Bank (Japan Health Sciences Foundation).17, 18 The human glioblastoma cell line LN229 was purchased from the Japanese Collection of Research Bioresources (JCRB) Cell Bank. The human metastatic mammary carcinoma cell line MCF‐7 (MCF‐7, JCRB0134) was purchased from JCRB Cell Bank.19 The human cardiac fibroblast adult cell line (No. 6330) (HCF) was purchased from ScienCell Research Laboratories.19, 20
+ Open protocol
+ Expand
3

Cell Culture Conditions and Sources

Check if the same lab product or an alternative is used in the 5 most similar protocols
COLO205 (a human colorectal cancer cell line) was obtained from the Cell Resource Center for Biomedical Research Institute of Development, Aging and Cancer at Tohoku University (Sendai, Japan). HSC-3 (a human OSCC cell line) and LN229 (a human glioblastoma cell line) were obtained from the Japanese Collection of Research Bioresources (Osaka, Japan). P3X63Ag8U.1 (P3U1: a mouse multiple myeloma) and CHO-K1 cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). HSC-3 and LN229 were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Nacalai Tesque, Inc., Kyoto, Japan), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS; Thermo Fisher Scientific, Inc., Waltham, MA, USA), 100 U/mL of penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B. CHO-K1, COLO205, and P3U1 were cultured in Roswell Park Memorial Institute (RPMI)-1640 medium (Nacalai Tesque, Inc.) supplemented with 10% FBS and antibiotics, as indicated above. All the cells were grown in a humidified incubator at 37 °C with 5% CO2.
+ Open protocol
+ Expand
4

Cell Line Culturing and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
A172, LN229 and T98G cell lines were purchased from the American Type Culture Collection (ATCC) (Manassas, VA) and KALS-1 were from JCRB cell bank (Osaka, Japan) (A172: ATCC Cat#CRL-1620, RRID:CVCL_0131, KALS-1: JCRB Cat#IFO50434, RRID:CVCL_1323, LN229: ATCC Cat#CRL-2611, RRID:CVCL_0393, T98G: Cat#CRL-1690, RRID:CVCL_0556). Cells were supplemented with Dulbecco’s modified Eagle’s medium (DMEM), 10% heat-inactivated foetal bovine serum and 1% penicillin-streptomycin at 37 °C in a humidified incubator with an atmosphere of 5% CO2. As a patient-derived brain tumour-initiating cell, HCM-BROD-0417-C71 was purchased from ATCC (Cat#PDM-379) and cultured with conditioned media supplemented with NeuroCult™ NS-A Proliferation Kit (Cat#05751; STEMCELL Technologies, Vancouver, Canada), 20 ng/mL EGF (Cat#236-EG-200; R&D Systems, Minneapolis, MN), 20 ng/mL bFGF (Cat#100-18B; Peprotech, Cranbury, NJ) and 2 µg/mL Heparin (Cat#07980; STEMCELL Technologies). All cells were used in experiments up to the 15th passage. Cells had been tested for mycoplasma (Venor Gem Classic; Minerva Biolabs, Berlin, Germany), the last test being in 07/02/2019.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!